5374 篇
13902 篇
477669 篇
16267 篇
11757 篇
3922 篇
6525 篇
1250 篇
75562 篇
37694 篇
12151 篇
1655 篇
2857 篇
3412 篇
641 篇
1239 篇
1973 篇
4910 篇
3867 篇
5451 篇
全球核酸测试市场报告(2016-2020年)
Global Nucleic Acid Testing Market 2016-2020
In-vitro diagnostics (IVD) is one of the most important segments of the global healthcare market. The tests and assays for the detection of various diseases such as cancer, tuberculosis and autoimmune diseases fall under the umbrella term of IVD market. IVD technologies has a wide range of applications in the field of clinical diagnosis. The market is dominated by the high sales of the reagents used in diagnosis, as most of the equipment are under rental or lease agreement with the enduser.
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 06: Market segmentation by product
Instruments
Reagents
PART 07: Market segmentation by indication
Market overview
Infectious diseases
Cancer
Genetics
PART 08: Market segmentation by technology
Polymerase chain reaction (PCR)
Strand displacement amplification (SDA)
Ligase chain reaction (LCR)
Others
PART 09: Market segmentation by end-users
Hospitals
Clinics
Research institutes
PART 10: Geographical segmentation
Nucleic acid testing market in Americas
Nucleic acid testing market in the EMEA
Nucleic acid testing market in the APAC
PART 11: Market drivers
Genome engineering and gene editing on rise
Higher adoption rate of molecular point-of-care (POC)
testing
Improved sensitivity for the detection systems
PART 12: Impact of drivers
PART 13: Market challenges
High cost of equipment and reagents
Stringent regulatory framework
Risks associated with molecular diagnosis
PART 14: Impact of drivers and challenges
PART 15: Market trends
Next generation sequencing
Higher adoption rate for NAT
Advances in precision and personalized medicine
PART 16: Vendor landscape
Competitive scenario
PART 17: Key vendor analysis
Abbott Laboratories
Roche Molecular Systems
Siemens Healthineers
Hologic
Qiagen
Key Companies to watch
Other prominent vendors
PART 18: Appendix
List of abbreviations
PART 19: Explore Technavio